Whitefort Capital Management »

Esperion Therapeutics shares owned by Whitefort Capital Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Whitefort Capital Management from 13F filings

Historical chart of Whitefort Capital Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Whitefort Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Whitefort Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.1M 2.3M 2.22
2023-12-31 $2.6M 886k 2.99

More positions owned by Whitefort Capital Management

Arbutus Biopharma (ABUS)
Roivant Sciences SHS (ROIV)
Nextnav Common Stock (NN)
Genworth Finl Com Shs (GNW)
Global Ship Lease Com Cl A (GSL)
Liberty Media Corp Del Com Lbty Srm S C (LSXMK)
Liquidia Corporation Com New (LQDA)
Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
Joyy Ads Repstg Com A (YY)
Esperion Therapeutics (ESPR)
Sabre Glbl Note 4.000% 4/1 (Principal)
Maiden Holdings SHS (MHLD)
Innovate Corp Note 7.500% 8/0 (Principal)
Odyssey Marine Expl Com New (OMEX)
Core Scientific (CORZ)

View all positions for Whitefort Capital Management

Top funds holding Esperion Therapeutics

Daniel D. Thurber
BlackRock
Vanguard Group
Bellevue Group
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Two Seas Capital
Woodline Partners
Marshall Wace
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Meditor
State Street Corporation
Morgan Stanley

View all funds holding Esperion Therapeutics